Literature DB >> 2273386

Localization of adenovirus-encoded DNA replication proteins in the nucleus by immunogold electron microscopy.

K G Murti1, D S Davis, G R Kitchingman.   

Abstract

The distribution of three adenovirus-encoded DNA replication proteins in the nucleus of human 293 cells was studied by immunogold electron microscopy. The infected nuclei contained four morphologically distinct inclusions. They were highly electron-dense granules (type I), compact fibrogranular masses of medium electron density (type II), filamentous masses of low electron density (type III) and large polygonal crystals (type IV). In immunogold labelling studies, antibodies to the adenovirus single-stranded DNA-binding protein (DBP) and antibodies to single-stranded DNA showed extensive binding to the type III inclusions. The antibodies to the adenovirus DNA polymerase (AdPol) and terminal protein (TP) predominantly labelled type II inclusions. Double immunogold labelling studies detected low levels of AdPol and TP in type III inclusions and DBP in type II inclusions. The selective distribution of DNA replication proteins suggests that the type II and III inclusions represent two functionally different entities that may be involved in two different aspects of adenovirus DNA replication, i.e. chain initiation and elongation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2273386     DOI: 10.1099/0022-1317-71-12-2847

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Intranuclear inclusions in paramyxovirus-induced encephalitis: evidence for altered nuclear body differentiation.

Authors:  M Oglesbee
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells.

Authors:  Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Morphological, Biochemical, and Functional Study of Viral Replication Compartments Isolated from Adenovirus-Infected Cells.

Authors:  Paloma Hidalgo; Lourdes Anzures; Armando Hernández-Mendoza; Adán Guerrero; Christopher D Wood; Margarita Valdés; Thomas Dobner; Ramón A Gonzalez
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

Review 4.  Viral and cellular interactions during adenovirus DNA replication.

Authors:  Matthew Charman; Christin Herrmann; Matthew D Weitzman
Journal:  FEBS Lett       Date:  2019-12-17       Impact factor: 4.124

Review 5.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

6.  Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix.

Authors:  P C Angeletti; J A Engler
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 7.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

8.  Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.

Authors:  Sayuri E Kato; Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  Compartmentalization of cellular and viral DNAs in adenovirus type 5 infection as revealed by ultrastructural in situ hybridization.

Authors:  S Besse; F Puvion-Dutilleul
Journal:  Chromosome Res       Date:  1994-03       Impact factor: 5.239

10.  Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.

Authors:  David K O'Brien; Stephen B Melville
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.